Thioredoxin Systems AB are officially a part of ENABLE-2. Within the frame of ENABLE-2, and with their team and network of world experts in antibiotics and AMR, we look forward to advancing the development of EbsArgent.
ENABLE-2 is a platform supported by Vetenskapsrådet / Swedish Research Council and the National Research Programme on Antibiotic Resistance with the aim to promote promising technologies in the pursuit of new antibiotics.
This is an archived news item, and TXN Systems is no longer participating in the ENABLE-2 programme.
